Malvern, Pennsylvania (PA) Noncommercial Research Organizations Companies

Featured companies
Delaware County Historical Soc
85 Malin Rd.
Malvern PA 19355
(610) 359-1148
Arlington Medical Resources
48 General Warren Blvd # 101
Malvern PA 19355
(610) 722-5511
Alteris Therapeutics Inc
26 Spring Mill Dr.
Malvern PA 19355
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

SCI Gro Mid Atlantic Inc
7 Great Valley Pkwy # 210
Malvern PA 19355
C P H Biomedical Inc
881 W King Rd.
Malvern PA 19355
Neuronyx Inc
1 Great Valley Pkwy # 20
Malvern PA 19355
(610) 240-4150
Sports Institute
20 Mystic Ln.
Malvern PA 19355
Ceptaris Therapeutics
101 Lindenwood Drive # 400
Malvern PA 19355
(610) 975-9290

Ceptaris Therapeutics is a privately held company in Malvern, PA and is a Unknown business.
C P H Biomedical Inc
881 West King Road
Malvern PA 19355
(610) 251-2240
Progenra Inc
271 Great Valley Parkway
Malvern PA 19355
(610) 644-6974
Cutanea Life Sciences Inc
5 Great Valley Parkway # 355
Malvern PA 19355
(484) 568-0100
Nox Technologies Inc
5 Reynard Road
Malvern PA 19355
Whereorg has 26 results under Noncommercial Research Organizations Companies in Malvern, PA.

Narrow down the browsing criteria below to see more companies.

Other locations for category Noncommercial Research Organizations


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020